![cover image](https://wikiwandv2-19431.kxcdn.com/_next/image?url=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d0/Bharat_Biotech_Covaxin_Bangalore_BESTpedia.jpg/640px-Bharat_Biotech_Covaxin_Bangalore_BESTpedia.jpg&w=640&q=50)
Covaxin
Vaccine against COVID-19 / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about BBV152?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
This article is about Bharat Biotech's COVID-19 vaccine. For Novavax's vaccine, see Covovax. For the global vaccine alliance, see COVAX.
Covaxin (development name, BBV152) is a whole inactivated virus-based COVID-19 vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research - National Institute of Virology.[1]
Quick Facts Vaccine description, Target ...
![]() | |
![]() A vial of Covaxin | |
Vaccine description | |
---|---|
Target | SARS-CoV-2 |
Vaccine type | Inactivated |
Clinical data | |
Trade names | Covaxin |
Routes of administration | Intramuscular |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
DrugBank | |
UNII |
Close
On 3 November 2021, the World Health Organization (WHO) validated the vaccine for emergency use, as the first Indian-developed covid vaccine to be approved.[2][3] By 31 January 2022, Covaxin had been granted emergency use approval in 13 countries.[4]